Why J&J vaccine is paused and some good news about Moderna

Federal health officials are taking extra time to study rare blood clots potentially associated with the Johnson & Johnson Covid-19 vaccine. Meanwhile, Moderna released some good news on the longterm efficacy of that company's vaccine. MSNBC Medical Contributor Dr. Nahid Bhadelia joins us to discuss.